Researchers Supported by the National MS Society Take Novel Gene-Immune Therapy Approach to Reverse Mouse Version of MS
September 23, 2017
Scientists at the University of Florida, funded in part by the National MS Society, took a novel approach to turn off immune attacks in mice with an MS-like disease. The team used a harmless virus to deliver a gene coding for a specific component of myelin, a key target of immune attacks in MS. This resulted in the activation of regulatory immune cells that suppressed the immune attack on the brain and spinal cord. This gene therapy approach prevented and reversed symptoms in the mice and was long-lasting. Further research is needed to verify and refine this approach before it can be tested in people.
Read about the study in University of Florida News
Read the original paper in Molecular Therapy
Read more about research aimed at stopping MS
About Multiple Sclerosis
Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. There is currently no cure for MS. Symptoms vary from person to person and range from numbness and tingling, to mobility challenges, blindness and paralysis. An estimated 1 million people live with MS in the United States. Most people are diagnosed between the ages of 20 and 50, and it affects women three times more than men.
About the National Multiple Sclerosis Society
The National MS Society, founded in 1946, funds cutting-edge research, drives change through advocacy, and provides programs and services to help people affected by MS live their best lives. Connect to learn more and get involved: nationalMSsociety.org, Facebook, Twitter, Instagram, YouTube or 1-800-344-4867.